Earth Buddy points to new feline cannabinoid research

Earth Buddy is highlighting new research in the Journal of Feline Medicine and Surgery that says cats process cannabinoids differently than humans and dogs. The findings could shape more precise CBD and CBDa formulations for feline pets.

Why it matters: - The research strengthens the case for species-specific pet formulations instead of one-size-fits-all cannabinoid products. - The findings suggest cats may respond better to lower cannabinoid concentrations, which could affect dosing and product design for feline wellness. - The study also supports broader veterinary use of clinical data when recommending hemp-based products for cats.

What happened: - Earth Buddy highlighted a new study in the Journal of Feline Medicine and Surgery titled "Cats and cannabinoids: past, present and future." - The study says cats have distinct cannabinoid metabolism compared with humans and dogs. - Earth Buddy is using the research to underscore its focus on feline-focused hemp extracts.

The details: - The study found cannabidiolic acid, or CBDa, is absorbed significantly better by cats than standard CBD. - The research says cats absorb CBDa three to four times more efficiently than CBD. - The study ties this difference to feline CYP450 enzymes and unique metabolic pathways. - Humans and dogs primarily convert CBD to 7-OH-CBD, while cats produce 6-OH-CBD. - The study also says cats have cannabinoid receptors throughout the body, including the gingiva, gastrointestinal tract and skin nodes. - Earth Buddy says its Mobility Hemp Extract and Balance Hemp Extract use cold-extraction methods that preserve CBDa alongside CBD. - Earth Buddy says those formulations are designed to match feline biological systems more closely.

Between the lines: - The research reinforces a growing push in pet care toward formulations based on species biology rather than broad cannabinoid assumptions. - For Earth Buddy, the study provides scientific support for a product strategy that already emphasizes CBDa in cat products. - The findings may also increase pressure on pet wellness brands to show more detailed evidence for dosage and ingredient choices.

What's next: - Earth Buddy plans to keep emphasizing evidence-based product development and education in the pet care market. - The company says it will continue focusing on science-backed hemp extracts for pet parents. - As veterinary interest in clinical data grows, species-specific dosing could become a more important standard in feline care.

The bottom line: - The new research gives Earth Buddy a scientific case for CBDa-first feline products and adds momentum to species-specific cannabinoid care for cats.